Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

FDA Clears Targeted Breast Cancer Radiation Treatment

The U.S. Food and Drug Administration approved a device that sends high doses of radiation to cancerous breast tissue while sparing healthy tissue nearby. . . . → Read More: FDA Clears Targeted Breast Cancer Radiation Treatment

Phone Sensors Shown to Monitor Chemotherapy Effects

Catheter for chemotherapy (Rhoda Baer, National Cancer Institute)

21 December 2017. A group of cancer patients was able to monitor the severity of effects of their chemotherapy with built-in sensors on smartphones and fitness trackers. Results of the clinical study, led by researchers at University of Pittsburgh, appear in the 19 December issue of . . . → Read More: Phone Sensors Shown to Monitor Chemotherapy Effects

FDA Approves Gene Therapy for Inherited Vision Loss

A therapy using transfers of healthy genes to treat a rare form of inherited vision loss was approved today by the U.S. Food and Drug Administration. . . . → Read More: FDA Approves Gene Therapy for Inherited Vision Loss

Biotechs Partner on HPV Cancer Immunotherapies

Biotechnology companies in the U.S. and the Netherlands are collaborating on treatments for cancers caused by a type of human papillomavirus, or HPV. . . . → Read More: Biotechs Partner on HPV Cancer Immunotherapies

FDA Issues Draft Precision Medicine Trial Guidance

The U.S. Food and Drug Administration issued draft regulatory guidance on clinical trials for new treatments that target genetic mutations rather than disease states. . . . → Read More: FDA Issues Draft Precision Medicine Trial Guidance

FDA Fast-Tracks Heart Failure Gene Therapy

A biotechnology company developing transfers of healthy genes to treat chronic diseases is receiving an accelerated review of its heart failure therapy from the U.S. Food and Drug Administration. . . . → Read More: FDA Fast-Tracks Heart Failure Gene Therapy

Current Drug Helps Cut Opioid Use After Surgery

Results from a clinical trial show patients given a current non-opioid pain medication with different types of surgery were less likely to use opioids for up to a year later. . . . → Read More: Current Drug Helps Cut Opioid Use After Surgery

MIT Building Statewide Health Innovation System

A unit of Massachusetts Institute of Technology is establishing what it calls an innovation ecosystem that pulls together different players in health care to better serve the needs of patients. . . . → Read More: MIT Building Statewide Health Innovation System

Consortium to Speed, Expand Alzheimer’s Clinical Trials

A group of medical centers is establishing a network of clinical trial sites and processes for testing new treatments for Alzheimer’s disease. . . . → Read More: Consortium to Speed, Expand Alzheimer’s Clinical Trials

CAR T-Cells Shown Effective in Long-Term Studies

Results from two clinical studies of engineered immune system cells show patients continue to respond their treatments after 6 months or more. . . . → Read More: CAR T-Cells Shown Effective in Long-Term Studies